Corebridge Financial’s Telomir Pharmaceuticals TELO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,472	Closed	-$30.6K	–	2898
2025 Q1	$30.6K	Sell	9,472 -141	-1%	-$455	﹤0.01%	2834
2024 Q4	$39.6K	Buy	9,613 +7,041	+274%	+$29K	﹤0.01%	2878
2024 Q3	$16.5K	Sell	2,572 -16	-0.6%	-$103	﹤0.01%	2992
2024 Q2	$12.5K	Buy	+2,588	New	+$12.5K	﹤0.01%	3020